EFS and breast cancer: Apoptotic responses of BC and normal breast cells to IBCar were evaluated using caspase-3/7 (Cas-3/7) activation assays (Figure 4A,B), as well as Western blot analyses of total and cleaved Cas-3 (Figure 4C), and PARP (Figure S4).